Literature DB >> 23030332

Candida parapsilosis and the neonate: epidemiology, virulence and host defense in a unique patient setting.

Brian D W Chow1, Jennifer R Linden, Joseph M Bliss.   

Abstract

Invasive candidiasis is a common problem in premature infants that leads to high morbidity and mortality. Although Candida albicans has historically been the most prominent species involved in these infections and has therefore been the subject of the most study, Candida parapsilosis is increasing in frequency, and neonates are disproportionately affected. This article reviews unique aspects of the epidemiology of this organism as well as strategies for prophylaxis against invasive candidiasis in general. Additionally, important differences between C. parapsilosis and C. albicans are coming to light related to virulence determinants and interactions with components of host immunity. These developments are reviewed while highlighting the significant gaps in our understanding that remain to be elucidated.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23030332      PMCID: PMC3498909          DOI: 10.1586/eri.12.74

Source DB:  PubMed          Journal:  Expert Rev Anti Infect Ther        ISSN: 1478-7210            Impact factor:   5.091


  109 in total

Review 1.  Prophylactic oral/topical non-absorbed antifungal agents to prevent invasive fungal infection in very low birth weight infants.

Authors:  Nicola Austin; Brian A Darlow; William McGuire
Journal:  Cochrane Database Syst Rev       Date:  2009-10-07

Review 2.  Adherence and biofilm formation of non-Candida albicans Candida species.

Authors:  Sónia Silva; Melyssa Negri; Mariana Henriques; Rosário Oliveira; David W Williams; Joana Azeredo
Journal:  Trends Microbiol       Date:  2011-03-15       Impact factor: 17.079

3.  Risk factors associated with gut and nasopharyngeal colonization by common Gram-negative species and yeasts in neonatal intensive care units patients.

Authors:  Ulle Parm; Tuuli Metsvaht; Epp Sepp; Mari-Liis Ilmoja; Heti Pisarev; Merit Pauskar; Irja Lutsar
Journal:  Early Hum Dev       Date:  2011-03-21       Impact factor: 2.079

Review 4.  Biology and genetics of the pathogenic yeast Candida parapsilosis.

Authors:  Jozef Nosek; Zuzana Holesova; Peter Kosa; Attila Gacser; Lubomir Tomaska
Journal:  Curr Genet       Date:  2009-08-07       Impact factor: 3.886

5.  Candida parapsilosis fat storage-inducing transmembrane (FIT) protein 2 regulates lipid droplet formation and impacts virulence.

Authors:  Long N Nguyen; Zsuzsanna Hamari; Bert Kadereit; David Trofa; Mariangela Agovino; Luis R Martinez; Attila Gacser; David L Silver; Joshua D Nosanchuk
Journal:  Microbes Infect       Date:  2011-03-21       Impact factor: 2.700

6.  Fatty acid synthase impacts the pathobiology of Candida parapsilosis in vitro and during mammalian infection.

Authors:  Long Nam Nguyen; David Trofa; Joshua D Nosanchuk
Journal:  PLoS One       Date:  2009-12-22       Impact factor: 3.240

7.  Biofilms of non-Candida albicans Candida species: quantification, structure and matrix composition.

Authors:  Sónia Silva; Mariana Henriques; António Martins; Rosário Oliveira; David Williams; Joana Azeredo
Journal:  Med Mycol       Date:  2009-11       Impact factor: 4.076

8.  Impact of antifungal prophylaxis on colonization and azole susceptibility of Candida species.

Authors:  Paul A Mann; Paul M McNicholas; Andrew S Chau; Reena Patel; Cara Mendrick; Andrew J Ullmann; Oliver A Cornely; Hernando Patino; Todd A Black
Journal:  Antimicrob Agents Chemother       Date:  2009-09-28       Impact factor: 5.191

Review 9.  Candida parapsilosis: a review of its epidemiology, pathogenesis, clinical aspects, typing and antimicrobial susceptibility.

Authors:  Eveline C van Asbeck; Karl V Clemons; David A Stevens
Journal:  Crit Rev Microbiol       Date:  2009       Impact factor: 7.624

10.  Complement receptor 3, not Dectin-1, is the major receptor on human neutrophils for beta-glucan-bearing particles.

Authors:  Robin van Bruggen; Agata Drewniak; Machiel Jansen; Michel van Houdt; Dirk Roos; Helen Chapel; Arthur J Verhoeven; Taco W Kuijpers
Journal:  Mol Immunol       Date:  2009-10-07       Impact factor: 4.407

View more
  21 in total

1.  Protection of Candida parapsilosis from neutrophil killing through internalization by human endothelial cells.

Authors:  Kyle A Glass; Sarah J Longley; Joseph M Bliss; Sunil K Shaw
Journal:  Virulence       Date:  2015       Impact factor: 5.882

Review 2.  The Candida pathogenic species complex.

Authors:  Siobhán A Turner; Geraldine Butler
Journal:  Cold Spring Harb Perspect Med       Date:  2014-09-02       Impact factor: 6.915

3.  Neonatal Candidiasis: New Insights into an Old Problem at a Unique Host-Pathogen Interface.

Authors:  Amanda B Arsenault; Joseph M Bliss
Journal:  Curr Fungal Infect Rep       Date:  2015-09-07

4.  Time to initiation of antifungal therapy for neonatal candidiasis.

Authors:  Jennifer Le; Tu T Tran; Ivilynn Bui; Mike K Wang; Andrew Vo; Felice C Adler-Shohet
Journal:  Antimicrob Agents Chemother       Date:  2013-03-18       Impact factor: 5.191

5.  Comparative Study of the Effects of Fluconazole and Voriconazole on Candida glabrata, Candida parapsilosis and Candida rugosa Biofilms.

Authors:  Priya Madhavan; Farida Jamal; Chong Pei Pei; Fauziah Othman; Arunkumar Karunanidhi; Kee Peng Ng
Journal:  Mycopathologia       Date:  2018-01-29       Impact factor: 2.574

6.  Human endothelial cells internalize Candida parapsilosis via N-WASP-mediated endocytosis.

Authors:  Tatsushi Shintaku; Kyle A Glass; Matthew P Hirakawa; Sarah J Longley; Richard J Bennett; Joseph M Bliss; Sunil K Shaw
Journal:  Infect Immun       Date:  2013-05-20       Impact factor: 3.441

Review 7.  Epidemiology of Invasive Fungal Disease in Children.

Authors:  Zoi Dorothea Pana; Emmanuel Roilides; Adilia Warris; Andreas H Groll; Theoklis Zaoutis
Journal:  J Pediatric Infect Dis Soc       Date:  2017-09-01       Impact factor: 3.164

8.  Clinical Analysis of Intravenous and Oral Sequential Treatment With Voriconazole for Candida Central Nervous System Infection in Six Premature Infants.

Authors:  Yingying Zhu; Xiaohui Gong; Zhiling Li; Danni Wang; Chongbing Yan
Journal:  Front Pharmacol       Date:  2021-06-24       Impact factor: 5.810

9.  Different Candida parapsilosis clinical isolates and lipase deficient strain trigger an altered cellular immune response.

Authors:  Renáta Tóth; Maria F Alonso; Judith M Bain; Csaba Vágvölgyi; Lars-Peter Erwig; Attila Gácser
Journal:  Front Microbiol       Date:  2015-10-13       Impact factor: 5.640

10.  The Candida Genome Database: the new homology information page highlights protein similarity and phylogeny.

Authors:  Jonathan Binkley; Martha B Arnaud; Diane O Inglis; Marek S Skrzypek; Prachi Shah; Farrell Wymore; Gail Binkley; Stuart R Miyasato; Matt Simison; Gavin Sherlock
Journal:  Nucleic Acids Res       Date:  2013-10-31       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.